학술논문

Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for transplant-ineligible myeloma: AMaRC 03-16
Document Type
Article
Source
In Blood Advances April 2024
Subject
Clinical Trials and Observations
Lymphoid Neoplasia
Language
ISSN
2473-9529